Starjemza's inclusion in Cost Plus Drugs' portfolio aims to challenge traditional specialty medication economics and enhance ...

Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) today announced the addition of Starjemza®, a new biosimilar medication, to its growing portfolio of affordable prescription drugs. Starjemza® ...

Cigna Group’s Express Scripts announced plans to offer a “cost-plus” drug pricing model for its clients next year amid growing scrutiny of pharmacy benefit managers. Employers, health plans and ...

"We're excited to partner with Mark Cuban Cost Plus Drugs, a company that shares our commitment to transparency, ...

President Trump promised to lower the cost of Ozempic to $150. Mark Cuban says he's working from the same playbook as Cost ...

GoodRx, a prescription savings company, launched a new offering on Monday that delivers a cost-plus pricing model for independent pharmacies. Santa Monica, California-based GoodRx helps consumers ...

Cigna's (NYSE:CI) pharmacy benefits management (PBM) unit, Express Scripts, announced on Tuesday a new program to offer its clients the option to pay cost-based pricing for prescription drugs and ...

Community Link allows independent pharmacies to direct contract with GoodRx, manage participation in the company’s Integrated Savings Program and other benefits. Manage Participation in GoodRx’s ...

Amazon is adding RxPass to its pharmacy footprint. Purportedly, it’s competing with Mark Cuban’s Cost Plus Drug Company (MCCPDC). But, limitations suggest it isn’t yet a real competitor. Moreover, ...

Cost Plus Drugs offers inexpensive generic prescription drugs, but it’s not a replacement for Medicare Part D coverage. Many, or all, of the products featured on this page are from our advertising ...